Honz Pharmaceutical (300086.SZ) forecasts a pre-loss, expecting a net loss for the year 2024 of between 154 million and 226 million yuan, turning from profit to loss.

Honz Pharmaceutical (300086.SZ) released a performance forecast for the year 2024, the company expects a net loss attributable to the shareholders of the listed company of 154 million to 226 million yuan in 2024, turning from profit to loss; after deducting non-recurring gains and losses, the net loss is expected to be 151 million to 222 million yuan, turning from profit to loss.